Credit Suisse’s Rocket Pharmaceuticals RCKT Stock Holding History

Credit Suisse’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$2.41M	Sell	89,280 -18	-0%	-$485	﹤0.01%	1726
2023 Q4	$2.68M	Buy	89,298 +13,745	+18%	+$412K	﹤0.01%	1706
2023 Q3	$1.55M	Sell	75,553 -12,043	-14%	-$247K	﹤0.01%	1983
2023 Q2	$1.74M	Buy	87,596 +16,865	+24%	+$335K	﹤0.01%	1994
2023 Q1	$1.21M	Buy	70,731 +5,256	+8%	+$90K	﹤0.01%	2194
2022 Q4	$1.28M	Buy	65,475 +34,321	+110%	+$672K	﹤0.01%	2151
2022 Q3	$497K	Sell	31,154 -67	-0.2%	-$1.07K	﹤0.01%	2760
2022 Q2	$429K	Buy	31,221 +876	+3%	+$12K	﹤0.01%	2925
2022 Q1	$481K	Buy	30,345 +2,043	+7%	+$32.4K	﹤0.01%	2988
2021 Q4	$618K	Buy	28,302 +1,643	+6%	+$35.9K	﹤0.01%	2886
2021 Q3	$797K	Buy	26,659 +2,106	+9%	+$63K	﹤0.01%	2733
2021 Q2	$1.09M	Buy	24,553 +30	+0.1%	+$1.33K	﹤0.01%	2570
2021 Q1	$1.09M	Sell	24,523 -145	-0.6%	-$6.43K	﹤0.01%	2526
2020 Q4	$1.35M	Sell	24,668 -43,978	-64%	-$2.41M	﹤0.01%	2374
2020 Q3	$1.57M	Buy	68,646 +30,089	+78%	+$688K	﹤0.01%	1979
2020 Q2	$807K	Buy	+38,557	New	+$807K	﹤0.01%	2423
2020 Q1	–	Sell	-49,289	Closed	-$1.12M	–	3475
2019 Q4	$1.12M	Sell	49,289 -22,106	-31%	-$503K	﹤0.01%	2431
2019 Q3	$831K	Buy	71,395 +19,637	+38%	+$229K	﹤0.01%	2517
2019 Q2	$776K	Buy	51,758 +35,027	+209%	+$525K	﹤0.01%	2519
2019 Q1	$294K	Sell	16,731 -11,034	-40%	-$194K	﹤0.01%	3022
2018 Q4	$411K	Buy	27,765 +17,880	+181%	+$265K	﹤0.01%	2840
2018 Q3	$244K	Sell	9,885 -7,605	-43%	-$188K	﹤0.01%	3122
2018 Q2	$343K	Buy	+17,490	New	+$343K	﹤0.01%	3124
2017 Q1	–	Sell	-3,755	Closed	-$91K	–	3566
2016 Q4	$91K	Buy	3,755 +128	+4%	+$3.1K	﹤0.01%	3598
2016 Q3	$138K	Buy	3,627 +70	+2%	+$2.66K	﹤0.01%	3537
2016 Q2	$106K	Sell	3,557 -9,069	-72%	-$270K	﹤0.01%	3735
2016 Q1	$374K	Buy	12,626 +8,441	+202%	+$250K	﹤0.01%	3107
2015 Q4	$189K	Buy	+4,185	New	+$189K	﹤0.01%	3686